The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.

[1]  T. Einarson,et al.  Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis. , 1999, Urology.

[2]  D J Hunter,et al.  Epidemiology of interstitial cystitis: a population based study. , 1999, The Journal of urology.

[3]  T. Warner,et al.  Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. , 1999, The Journal of urology.

[4]  N. Wiklund,et al.  Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis. , 1998, Urology.

[5]  V. P. Bhavanandan,et al.  Increased urinary hyaluronic acid and interstitial cystitis. , 1998, The Journal of urology.

[6]  J. Schmidt,et al.  Elevated Stress Protein in Transitional Cells Exposed to Urine from Interstitial Cystitis Patients , 1998, International journal of urology : official journal of the Japanese Urological Association.

[7]  C. Parsons,et al.  The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. , 1998, The Journal of urology.

[8]  G. Sant,et al.  Interstitial Cystitis: A Neuroimmunoendocrine Disorder a , 1998, Annals of the New York Academy of Sciences.

[9]  E. Messing,et al.  Long-term experience with pentosanpolysulfate in interstitial cystitis. , 1998, Urology.

[10]  E. McGuire,et al.  The incidence of Helicobacter pylori in patients with interstitial cystitis. , 1998, The Journal of urology.

[11]  D. Dabbs,et al.  Inflammatory cell types and clinical features of interstitial cystitis. , 1997, The Journal of urology.

[12]  A. Pattanaik,et al.  Evidence for altered proliferative ability of progenitors of urothelial cells in interstitial cystitis. , 1997, The Journal of urology.

[13]  C. Öbek,et al.  Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. , 1997, Cancer research.

[14]  J. B. Roy,et al.  A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. , 1996, Urology.

[15]  N Iida,et al.  The Cell Adhesion Molecule, GP116, Is a New CD44 Variant (ex14/v10) Involved in Hyaluronic Acid Binding and Endothelial Cell Proliferation* , 1996, The Journal of Biological Chemistry.

[16]  J. Nickel,et al.  Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. , 1996, Urology.

[17]  S. Pham,et al.  Monitoring of acute lung rejection and infection by bronchoalveolar lavage and plasma levels of hyaluronic acid in clinical lung transplantation. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  P. Hanno,et al.  Current findings and future research avenues in the study of interstitial cystitis. , 1994, The Urologic clinics of North America.

[19]  L. Knight,et al.  Bladder permeability in interstitial cystitis is similar to that of normal volunteers: direct measurement by transvesical absorption of 99mtechnetium-diethylenetriaminepentaacetic acid. , 1994, The Journal of urology.

[20]  J. Nickel,et al.  The bladder mucus (glycosaminoglycan) layer in interstitial cystitis. , 1993, The Journal of urology.

[21]  C. Underhill,et al.  CD44: the hyaluronan receptor. , 1992, Journal of cell science.

[22]  J. D. Lilly,et al.  Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). , 1991, The Journal of urology.

[23]  G. Sant,et al.  Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. , 1990, Urology.

[24]  R. Hurst,et al.  Decreased urinary uronic acid levels in individuals with interstitial cystitis. , 1990, The Journal of urology.

[25]  M. Fall,et al.  Scanning electron microscopic findings in interstitial cystitis. , 1989, British journal of urology.

[26]  D. Buttle,et al.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.

[27]  E. Bostofte,et al.  Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis. , 1986, The Journal of urology.

[28]  B. Toole,et al.  Binding of hyaluronate to the surface of cultured cells , 1979, The Journal of cell biology.

[29]  J. A. Cifonelli,et al.  The acid mucopolysaccharides in normal urine. , 1967, Biochimica et biophysica acta.

[30]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.

[31]  D. Porru,et al.  Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. , 1997, Urologia internationalis.

[32]  V. P. Bhavanandan,et al.  Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis. , 1997, The Journal of urology.

[33]  R. Hurst,et al.  Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis. , 1993, The Journal of urology.

[34]  R. Hurst,et al.  Bladder surface glycosaminoglycans: an epithelial permeability barrier. , 1990, The Journal of urology.

[35]  Oravisto Kj.  Interstitial cystitis as an autoimmune disease. A review. , 1980 .